Explainer
Mpox explained: clades I and II, symptoms, vaccines and emergencies
Mpox, formerly called monkeypox, is a viral illness that spreads mainly through close contact, including skin-to-skin contact and sex.[1][2] The virus has two clades: clade IIb drove the global outbreak that began in 2022, while clades Ia and Ib caused growing outbreaks in the Democratic Republic of the Congo and other African countries.[3][4] WHO declared mpox a global health emergency twice, in May 2022 and August 2024, and ended the second emergency on 5 September 2025.[5][6] Vaccines are recommended for people at high risk; there is no proven antiviral treatment.[7][8]
This page explains mpox for general readers. It is not medical advice. If you have a new rash or sores and think you may have been exposed to mpox, contact a clinician or sexual health service, and avoid close contact with others until you have been advised.
Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus.[1] The virus was discovered in research monkeys in Denmark in 1958, and the first reported human case was a nine-month-old boy in the Democratic Republic of the Congo in 1970.[9]
Clades I and II
The monkeypox virus has two distinct clades: clade I, with subclades Ia and Ib, and clade II, with subclades IIa and IIb.[3] A global outbreak of clade IIb began in 2022. Clades Ia and Ib have caused growing outbreaks in the Democratic Republic of the Congo and other African countries, and clade Ib had been detected outside Africa by August 2024.[4]
How it spreads and what it does
Mpox spreads mainly through close contact with someone who has it, including household members. Close contact includes skin-to-skin contact such as touching or sex, and mouth-to-skin contact such as kissing. People can also catch it from contaminated objects such as clothing or bedding, and from infected animals through bites or scratches.[2]
Symptoms include a rash, fever, sore throat, headache, muscle aches, back pain, low energy and swollen lymph nodes. The rash often starts on the face and spreads across the body to the palms and soles.[10] People can pass mpox on until all their sores have healed and a new layer of skin has formed.[11]
Most people fully recover. Children, pregnant people and people with weakened immune systems, including people with poorly controlled HIV, are at higher risk of serious illness and death.[12]
Testing, treatment and vaccines
The preferred test is PCR detection of viral DNA, ideally from swabs of the rash. WHO says adults with mpox should be offered an HIV test.[13] For people with HIV who have mpox and are not on treatment, WHO strongly recommends starting antiretroviral therapy quickly; see HIV explainer.[14]
There is no proven effective antiviral treatment for mpox. Care focuses on looking after the rash, managing pain and preventing complications.[8]
WHO recommends vaccination for people at high risk of mpox, especially during an outbreak. Vaccine can also be given after contact with someone who has mpox; WHO says it should be given within 4 days of that contact.[7] A global mpox vaccine stockpile, funded by Gavi and coordinated by the International Coordinating Group on Vaccine Provision, was launched on 27 August 2026.[15]
Two global emergencies
WHO has declared mpox a public health emergency of international concern (PHEIC) twice: in May 2022 and again in August 2024.[5] In the year before September 2025, the WHO African Region accounted for over 80% of mpox cases reported worldwide.[16]
On 5 September 2025, on the advice of the International Health Regulations Emergency Committee, WHO’s Director-General determined that the 2024 upsurge no longer constituted a PHEIC.[6] Ending the emergency did not end the disease: from 1 January 2022 to 31 July 2026, 145 countries and territories reported 190,683 confirmed cases and 529 deaths.[17]
Read next
Measles explained: symptoms, MMR vaccine and elimination status
What measles is, how it spreads, its complications, how well the MMR vaccine works, and why Canada lost and the US risks losing elimination status.
Questions readers ask
How does mpox spread?
Mainly through close contact with someone who has mpox, including skin-to-skin contact, sex and kissing. It can also spread through contaminated objects such as clothing or bedding, during pregnancy, and from infected animals.[2]
What are the symptoms of mpox?
A rash, fever, sore throat, headache, muscle aches, back pain, low energy and swollen lymph nodes. The rash often starts on the face and spreads to the palms and soles.[10]
How long is someone with mpox infectious?
WHO says people with mpox can pass it on until all sores have healed and a new layer of skin has formed.[11]
What is the difference between clade I and clade II?
They are the two distinct branches of the monkeypox virus, each with subclades (Ia and Ib; IIa and IIb). Clade IIb caused the global outbreak from 2022; clades Ia and Ib have driven outbreaks in the Democratic Republic of the Congo and elsewhere in Africa.[3][4]
Is there an mpox vaccine?
Yes. WHO recommends vaccination for people at high risk, especially during outbreaks, and says vaccine given within 4 days of contact with a case can also serve as post-exposure protection.[7]
Sources
· 17 claims from 1 publisher
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
Mpox, previously called monkeypox, is a viral illness caused by the monkeypox virus, an orthopoxvirus. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Key facts (retrieved 2026-11-07)
- [2]
Mpox spreads mainly through close contact with someone who has it, including skin-to-skin contact, sex and kissing; it can also spread from contaminated objects, during pregnancy, and from infected animals. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Transmission (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Transmission (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Transmission (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Transmission (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Transmission (retrieved 2026-11-07)
- [3]
The virus has two clades: clade I (subclades Ia and Ib) and clade II (subclades IIa and IIb). confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Key facts (retrieved 2026-11-07)
- [4]
A global clade IIb outbreak began in 2022, and clades Ia and Ib have caused growing outbreaks in the Democratic Republic of the Congo and other African countries; clade Ib was detected outside Africa by August 2024. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
- [5]
WHO has declared mpox a public health emergency of international concern twice: in May 2022 and in August 2024. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · WHO response (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · WHO response (retrieved 2026-11-07)
- [6]
On 5 September 2025 WHO's Director-General determined that the 2024 mpox upsurge no longer constituted a PHEIC, on the advice of the IHR Emergency Committee. confirmedas of 2026-11-07
- Fifth meeting of the IHR (2005) Emergency Committee regarding the upsurge of mpox 2024 · World Health Organization · Primary source · 2025-10-30 · Paragraph 1: "on 5 September 2025" (retrieved 2026-11-07)
- Fifth meeting of the IHR (2005) Emergency Committee regarding the upsurge of mpox 2024 · World Health Organization · Primary source · 2025-10-30 (retrieved 2026-11-07)
- [7]
WHO recommends mpox vaccination for people at high risk, especially during outbreaks, and says vaccine given within 4 days of contact can serve as post-exposure prophylaxis. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Treatment and vaccination (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Treatment and vaccination (retrieved 2026-11-07)
- [9]
The monkeypox virus was discovered in research monkeys in Denmark in 1958, and the first human case was a nine-month-old boy in the Democratic Republic of the Congo in 1970. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Outbreaks (retrieved 2026-11-07)
- [10]
Mpox symptoms include a rash, fever, sore throat, headache, muscle aches, back pain, low energy and swollen lymph nodes; the rash often starts on the face and spreads to the palms and soles. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Signs and symptoms (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Signs and symptoms (retrieved 2026-11-07)
- [11]
People with mpox can pass it on until all sores have healed and a new layer of skin has formed. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Signs and symptoms (retrieved 2026-11-07)
- [12]
Most people fully recover from mpox, but children, pregnant people and people with weakened immune systems, including poorly controlled HIV, face higher risk of serious illness and death. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Signs and symptoms (retrieved 2026-11-07)
- [13]
The preferred test for mpox is PCR detection of viral DNA from rash swabs, and WHO says HIV testing should be offered to adults with mpox. confirmedas of 2026-11-07
- Mpox - fact sheet · World Health Organization · Primary source · Diagnosis (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Diagnosis (retrieved 2026-11-07)
- Mpox - fact sheet · World Health Organization · Primary source · Diagnosis (retrieved 2026-11-07)
- [14]
WHO strongly recommends rapid start of antiretroviral therapy for people with HIV and mpox who are not on treatment. confirmedas of 2026-11-07
- WHO recommends injectable lenacapavir for HIV prevention · World Health Organization · Primary source · 2025-07-14 · Additional WHO recommendations at IAS 2025 (retrieved 2026-11-07)
- [15]
A global mpox vaccine stockpile, funded by Gavi and coordinated by the International Coordinating Group on Vaccine Provision, was launched on 27 August 2026. confirmedas of 2026-11-07
- Global initiative launched to improve access to mpox vaccines · World Health Organization · Primary source · 2026-09-02 · Paragraph 1; published 2 September 2026 (retrieved 2026-11-07)
- Global initiative launched to improve access to mpox vaccines · World Health Organization · Primary source · 2026-09-02 · Paragraph 1 (retrieved 2026-11-07)
- [17]
From 1 January 2022 to 31 July 2026, 145 countries and territories reported 190,683 confirmed mpox cases and 529 deaths. confirmedas of 2026-11-07
- Global initiative launched to improve access to mpox vaccines · World Health Organization · Primary source · 2026-09-02 · Paragraph 3 (retrieved 2026-11-07)
Revision history (1)
- Page created.
Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 28, 2027.
Cite this page
"Mpox explained: clades I and II, symptoms, vaccines and emergencies." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/mpox-explained
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.